---
annotations:
- type: Pathway Ontology
  value: selenoamino acid metabolic pathway
authors:
- ReactomeTeam
- Lindarieswijk
description: Selenium (Se) is a trace element essential for the normal function of
  the body.  Selenoamino acids are defined as those amino acids where selenium has
  been substituted for sulphur.  Selenium and sulphur share many chemical properties
  and so the substitution of normal amino acids with selenoamino acids has little
  effect on protein structure and function.  Both inorganic (selenite, SeO3(2-); and
  selenate, SeO4(2-)) and organic (selenocysteine, Sec; and selenomethionine, SeMet)
  forms of selenium can be introduced in the diet where they are transformed into
  the intermediate selenide (Se(2-)) and then utilized for the <I>de novo</I> synthesis
  of Sec through a phosphorylated intermediate in a tRNA-dependent fashion. The final
  step of Sec formation is catalyzed by O-phosphoseryl-tRNA:selenocysteinyl-tRNA synthase
  (SEPSECS) that converts phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).<br><br>All
  nutritional selenium is metabolised into selenide directly or through methylselenol
  (MeSeH).  Sec liberated from selenoproteins is transformed to Se(2-) by selenocysteine
  lyase (SCLY).  SeMet liberated from general proteins and from free SeMet sources
  is transformed into Se(2-) either through MeSeH by cystathionine gamma-lyase (CTH)
  followed by demethylation (SeMet to CH3SeH to H2Se), or through Sec by SCLY after
  the trans-selenation pathway (SeMet to Sec to H2Se). MeSec is hydrolysed into MeSeH
  by CTH.  Methylseleninic acid (MeSeO2H) is reduced to methylselenol. MeSeH is demethylated
  to Se(2-) for further utilization for selenoprotein synthesis or oxidised to selenite
  (SeO3(2-)) for excretion in the form of selenosugar. Additionally, MeSeH is further
  methylated to dimethylselenide (Me2Se) and trimethylselenonium (Me3Se+) for excretion.  View
  original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2408522 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3791
- /instance/WP3791
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3791.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Selenium (Se) is a trace element essential for the normal function
    of the body.  Selenoamino acids are defined as those amino acids where selenium
    has been substituted for sulphur.  Selenium and sulphur share many chemical properties
    and so the substitution of normal amino acids with selenoamino acids has little
    effect on protein structure and function.  Both inorganic (selenite, SeO3(2-);
    and selenate, SeO4(2-)) and organic (selenocysteine, Sec; and selenomethionine,
    SeMet) forms of selenium can be introduced in the diet where they are transformed
    into the intermediate selenide (Se(2-)) and then utilized for the <I>de novo</I>
    synthesis of Sec through a phosphorylated intermediate in a tRNA-dependent fashion.
    The final step of Sec formation is catalyzed by O-phosphoseryl-tRNA:selenocysteinyl-tRNA
    synthase (SEPSECS) that converts phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).<br><br>All
    nutritional selenium is metabolised into selenide directly or through methylselenol
    (MeSeH).  Sec liberated from selenoproteins is transformed to Se(2-) by selenocysteine
    lyase (SCLY).  SeMet liberated from general proteins and from free SeMet sources
    is transformed into Se(2-) either through MeSeH by cystathionine gamma-lyase (CTH)
    followed by demethylation (SeMet to CH3SeH to H2Se), or through Sec by SCLY after
    the trans-selenation pathway (SeMet to Sec to H2Se). MeSec is hydrolysed into
    MeSeH by CTH.  Methylseleninic acid (MeSeO2H) is reduced to methylselenol. MeSeH
    is demethylated to Se(2-) for further utilization for selenoprotein synthesis
    or oxidised to selenite (SeO3(2-)) for excretion in the form of selenosugar. Additionally,
    MeSeH is further methylated to dimethylselenide (Me2Se) and trimethylselenonium
    (Me3Se+) for excretion.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=2408522
    Reactome].
  keywords:
  - 'MNA '
  - 'RPSA '
  - '5.8S rRNA '
  - 'RPS14 '
  - 'GTP '
  - 'RPL22 '
  - INMT
  - 'RPS19 '
  - EEFSEC:GTP
  - ADP
  - SECISBP2
  - 'RPL31 '
  - 'RPL8 '
  - synthetase
  - 'RPS15 '
  - TNXRD1:FAD dimer
  - 'RPS5 '
  - '18S rRNA '
  - PXLP-K284-SEPSECS
  - 'RPL41 '
  - 'FAD '
  - 'RPS27 '
  - 'RPL36A '
  - SeMet
  - 'RPL35A '
  - 'SECISBP2 '
  - 'RPS17 '
  - 'SARS '
  - 'PXLP-K259-SCLY '
  - 'RPL34 '
  - 'RPL3L '
  - Me2Se
  - 'MeHist '
  - 'PXLP-K284-SEPSECS '
  - SELP
  - 'QARS '
  - PAPSe
  - PAPSS1,2
  - bGalNAc
  - 'LARS '
  - tetramer
  - tRNA(Met)
  - PXLP-K212-CTH
  - EEFSEC:GDP
  - 'RPL10A '
  - AdoMet
  - SARS dimer
  - SEPHS2
  - 'Hist '
  - 80S:Met-tRNAi:mRNA:SECISBP2:Sec
  - PSTK:Mg2+
  - 'HNMT '
  - 'RPS13 '
  - MeSeOH
  - 'RPL23 '
  - 'Mg2+ '
  - GSSebGalNac
  - bGalNAc derivative
  - 'IARS '
  - PAPSeR
  - 'RPLP0 '
  - 'RPS10 '
  - 'RPL3 '
  - 'RPL10L '
  - 'RPS3A '
  - 'RPL39L '
  - L-Ser
  - acceptor
  - 'DARS '
  - NADPH
  - 'RPL40 '
  - SeHCys
  - NADP+
  - Ser-tRNA(Sec)
  - 'RPL21 '
  - pyruvic acid
  - '28S rRNA '
  - 'FAU '
  - HSeMT
  - 'RPL28 '
  - AdoHcy
  - 'RPS12 '
  - 'EEFSEC '
  - 'RPS29 '
  - 'RPL22L1 '
  - GSSeH
  - MSDM
  - SeO3(2-)
  - 'RPS4Y1 '
  - 'PAPSS1 '
  - 'RPL5 '
  - 'RPL26L1 '
  - 'Gly '
  - 'RPS4X '
  - 'RPS11 '
  - 'RPS28 '
  - Pi
  - 'GNMT '
  - AMP
  - Ade-Rib
  - AHCY
  - MeSeH
  - 'PXLP-K212-CTH '
  - 'RPL26 '
  - 'Met-tRNAi '
  - 'AIMP2 '
  - H2Se
  - tRNA(Sec)
  - AdoSeMet
  - 'RPS26 '
  - Me3Se+
  - 'RPL17 '
  - 'RPL35 '
  - MeSeHMT
  - MeSebGalNac
  - 'RPS24 '
  - PAP
  - 'Sec '
  - Sep-tRNA(Sec)
  - 'RPL13 '
  - 'Sec-tRNA(Sec) '
  - MeSeO2H
  - 'RPL11 '
  - 'RPL27A '
  - 'RPL24 '
  - 'EEF1E1 '
  - 'RPS15A '
  - H2O
  - 'RPS9 '
  - L-Ala
  - 'RPL36 '
  - 'RPL27 '
  - 'PAPSS2 '
  - 'RPS23 '
  - 'RPL38 '
  - PXLP-K119-CBS
  - 'RPL30 '
  - Sec
  - 'K+ '
  - 'RPL14 '
  - SeMet-tRNA(Met)
  - H2SeO4
  - 'RPL29 '
  - 'MAT1A '
  - 'NAM '
  - 'TXNRD1 '
  - 'heme '
  - 'RPS20 '
  - 'RPL36AL '
  - 'mRNA '
  - 'RPS27A(77-156) '
  - 'RARS '
  - 'RPS21 '
  - 'RPS25 '
  - 'AIMP1(1-312) '
  - GSR-2:FAD dimer
  - AdeSeHCys
  - 'RPL32 '
  - 'GSR-2 '
  - 'RPL15 '
  - 'RPL23A '
  - 'SARC '
  - 'RPL37 '
  - 'PSTK '
  - reduced acceptor
  - 'RPL4 '
  - 'RPS6 '
  - GSH
  - 'RPS8 '
  - 'RPL7A '
  - multienzyme complex
  - aminoacyl-tRNA
  - H+
  - GSSeSG
  - 'RPS2 '
  - SeCysta
  - 'RPL39 '
  - 'RPL9 '
  - GSSG
  - PXLP-K259-SCLY dimer
  - 'RPL12 '
  - MeHist,N1MNA,MeGly
  - NH3
  - PPi
  - Sec-tRNA(Sec):EEFSEC:GTP
  - 'MARS '
  - 'RPL19 '
  - 'RPLP2 '
  - 'PXLP-K119-CBS '
  - 'RPS16 '
  - 'RPS27L '
  - 2-acetamidoglucal
  - '5S rRNA '
  - 80S:Met-tRNAi:mRNA
  - 'RPL13A '
  - 'GDP '
  - 'RPL6 '
  - MeOH
  - 'RPS4Y2 '
  - 'KARS '
  - MeSec
  - Sec-tRNA(Sec)
  - 'RPL18 '
  - 'RPLP1 '
  - ATP
  - 'RPS7 '
  - APSe
  - MetTrans(1)
  - 'RPL10 '
  - 'RPL7 '
  - 80S:Met-tRNAi:mRNA:SECISBP2:Sec-tRNA(Sec):EEFSEC:GTP
  - MAT1A multimers
  - 'RPL37A '
  - 'RPS18 '
  - 'RPL18A '
  - Hist,NAM,Gly
  - 2OBUTA
  - 'EPRS '
  - 'RPS3 '
  - 'NNMT '
  license: CC0
  name: Selenoamino acid metabolism
seo: CreativeWork
title: Selenoamino acid metabolism
wpid: WP3791
---